Evidence map›Paper›PMID 33173285›Full record

ReviewClinical interventions in aging2020

Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure.

Helena Krysztofiak, Marta Wleklik, Jacek Migaj, Magdalena Dudek, Izabella Uchmanowicz, Magdalena Lisiak, Grzegorz Kubielas, Ewa Straburzyńska-Migaj, Maciej Lesiak, Marta Kałużna-Oleksy

Abstract readReview
In one paragraph

Review in Clinical interventions in aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Multimodal interventions for cachexia management.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. The lived experience of renal cachexia: An interpretive phenomenological analysis.International journal of nursing studies advances · 2024
    Article
  14. Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Review
  15. Review
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Helena Krysztofiak1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.ORCID 0000-0003-0748-9059
Marta WleklikDepartment of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0001-9574-4448
Jacek Migaj1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.ORCID 0000-0002-7962-3934
Magdalena Dudek1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.ORCID 0000-0001-6550-6182
Izabella UchmanowiczDepartment of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0002-8002-2052
Magdalena LisiakDepartment of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0003-4038-7492
Grzegorz KubielasDepartment of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0003-1229-0650
Ewa Straburzyńska-Migaj1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.ORCID 0000-0002-0545-3370
Maciej Lesiak1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.ORCID 0000-0003-2630-5016
Marta Kałużna-Oleksy1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.ORCID 0000-0003-4048-6247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is a common complication of various cardiac diseases, and its incidence constantly increases. This is caused mainly by aging of populations and improvement in the treatment of coronary artery disease. As HF patients age, they tend to develop comorbidities, creating new problems for health-care professionals. Sarcopenia, defined as the loss of muscle mass and function, and cachexia, defined as weight loss due to an underlying illness, are muscle wasting disorders of particular relevance in the heart failure population, but they go mostly unrecognized. The coexistence of chronic HF and metabolic disorders facilitates the development of cachexia. Cachexia, in turn, significantly worsens a patient's prognosis and quality of life. The mechanisms underlying cachexia have not been explained yet and require further research. Understanding its background is crucial in the development of treatment strategies to prevent and treat tissue wasting. There are currently no specific European guidelines or recommended therapy for cachexia treatment in HF ("cardiac cachexia").

Indexed as

AgingCachexiaChronic DiseaseComorbidityEuropeHeart FailureHumansPrognosisQuality of LifeRisk FactorsSarcopeniacardiac cachexiaheart failurenutritional status

Identifiers

PMID33173285
PMCPMC7646468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.